Published in Level 2 journals, first or last author from Oslo University Hospital.
Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, Masilamani T, Theriault G, St-Onge R, D'costa L, Lingjaerde OC, Haugen MH, Engebraaten O(2025) High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy Breast Cancer Res, 27(1), 143 DOI 10.1186/s13058-025-02092-9, PubMed 40790765
Edvardsen HME, Clausen T, Bogstrand ST, Skurtveit S(2025) The role of prescribed opioids in Norwegian overdose deaths in 2005-2021 Eur J Clin Pharmacol(in press) DOI 10.1007/s00228-025-03897-5, PubMed 40784976
Af Segerstad EMH, Guo A, Mårild K, Stene LC, Brantsæter AL, Størdal K, HEDIMED Investigator Group(2025) Associations of early life dietary diversity and healthy eating with celiac disease: A prospective cohort study Clin Nutr, 52, 171-178(in press) DOI 10.1016/j.clnu.2025.07.012, PubMed 40780128
